Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
285.40
-3.60 (-1.25%)
At close: Apr 17, 2025, 4:00 PM HKT

HKG:6990 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,9331,540803.9332.32
Revenue Growth (YoY)
25.48%91.62%2387.26%-
Cost of Revenue
659.39781.31277.1423.07
Gross Profit
1,274759.19526.89.25
Selling, General & Admin
346.03201.4193.0390.98
Research & Development
1,2061,031845.98727.67
Other Operating Expenses
-66.39-19.49-18.27-14.16
Operating Expenses
1,4861,213920.75804.49
Operating Income
-212.12-453.7-393.95-795.24
Interest Expense
-3.8-84.31-148.81-112.59
Interest & Investment Income
34.1845.191.420.81
Currency Exchange Gain (Loss)
17.7916.09-31.9416.88
EBT Excluding Unusual Items
-163.95-476.74-573.3-890.15
Gain (Loss) on Sale of Investments
21.5510.530.510.36
Gain (Loss) on Sale of Assets
-0.15-1.495.42-0.01
Pretax Income
-142.55-467.69-567.36-889.8
Income Tax Expense
124.22106.4448.74-
Net Income
-266.77-574.13-616.1-889.8
Preferred Dividends & Other Adjustments
--51.93-68-67.25
Net Income to Common
-266.77-522.21-548.1-822.55
Shares Outstanding (Basic)
2221849692
Shares Outstanding (Diluted)
2221849692
Shares Change (YoY)
20.70%92.24%3.31%-
EPS (Basic)
-1.20-2.84-5.74-8.90
EPS (Diluted)
-1.20-2.84-5.74-8.90
Free Cash Flow
-507.23-21.42-304.51-580.03
Free Cash Flow Per Share
-2.29-0.12-3.19-6.27
Gross Margin
65.89%49.28%65.53%28.62%
Operating Margin
-10.97%-29.45%-49.00%-2460.37%
Profit Margin
-13.80%-33.90%-68.18%-2544.86%
Free Cash Flow Margin
-26.24%-1.39%-37.88%-1794.52%
EBITDA
-163.83-419.78-367.99-775.61
EBITDA Margin
-8.48%-27.25%-45.77%-
D&A For EBITDA
48.2933.9225.9719.63
EBIT
-212.12-453.7-393.95-795.24
EBIT Margin
-10.97%-29.45%-49.00%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.